The Role of Immunotherapy in Multiple Myeloma

被引：22

作者：

Kocoglu, Mehmet ^{[1
]}

Badros, Ashraf ^{[1
]}

机构：

[1] Univ Maryland, Med Ctr, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA

来源：

PHARMACEUTICALS | 2016年 / 9卷 / 01期

关键词：

myeloma; immunotherapy; vaccines; tumor antigens; antibodies; CAR-T; adoptive cell therapy;

D O I：

10.3390/ph9010003

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Multiple myeloma is the second most common hematologic malignancy. The treatment of this disease has changed considerably over the last two decades with the introduction to the clinical practice of novel agents such as proteasome inhibitors and immunomodulatory drugs. Basic research efforts towards better understanding of normal and missing immune surveillence in myeloma have led to development of new strategies and therapies that require the engagement of the immune system. Many of these treatments are under clinical development and have already started providing encouraging results. We, for the second time in the last two decades, are about to witness another shift of the paradigm in the management of this ailment. This review will summarize the major approaches in myeloma immunotherapies.

引用

页数：13

共 57 条

[1]

[Anonymous], 2014, BLOOD, DOI DOI 10.1182/BLOOD.V124.21.291.291

[2] A Phase II Study of Anti PD-1 Antibody Pembrolizumab, Pomalidomide and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) [J].

Badros, Ashraf Z. ;

Kocoglu, Mehmet H. ;

Ma, Ning ;

Rapoport, Aaron P. ;

Lederer, Emily ;

Philip, Sunita ;

Lesho, Patricia ;

Dell, Cameron ;

Hardy, Nancy M. ;

Yared, Jean ;

Goloubeva, Olga ;

Singh, Zeba .

BLOOD, 2015, 126 (23)

[3] A multiepitope of XBP1, CD138 and CS1 peptides induces myeloma-specific cytotoxic T lymphocytes in T cells of smoldering myeloma patients [J].

Bae, J. ;

Prabhala, R. ;

Voskertchian, A. ;

Brown, A. ;

Maguire, C. ;

Richardson, P. ;

Dranoff, G. ;

Anderson, K. C. ;

Munshi, N. C. .

LEUKEMIA, 2015, 29 (01) :218-229

[4] Myeloma-Specific Multiple Peptides Able to Generate Cytotoxic T Lymphocytes: A Potential Therapeutic Application in Multiple Myeloma and Other Plasma Cell Disorders [J].

Bae, Jooeun ;

Smith, Robert ;

Daley, John ;

Mimura, Naoya ;

Tai, Yu-Tzu ;

Anderson, Kenneth C. ;

Munshi, Nikhil C. .

CLINICAL CANCER RESEARCH, 2012, 18 (17) :4850-4860

[5] The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody [J].

Benson, Don M., Jr. ;

Bakan, Courtney E. ;

Mishra, Anjali ;

Hofmeister, Craig C. ;

Efebera, Yvonne ;

Becknell, Brian ;

Baiocchi, Robert A. ;

Zhang, Jianying ;

Yu, Jianhua ;

Smith, Megan K. ;

Greenfield, Carli N. ;

Porcu, Pierluigi ;

Devine, Steven M. ;

Rotem-Yehudar, Rinat ;

Lozanski, Gerard ;

Byrd, John C. ;

Caligiuri, Michael A. .

BLOOD, 2010, 116 (13) :2286-2294

[6] Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies [J].

Berger, Raanan ;

Rotem-Yehudar, Rinat ;

Slama, Gideon ;

Landes, Shimon ;

Kneller, Abraham ;

Leiba, Merav ;

Koren-Michowitz, Maya ;

Shimoni, Avichai ;

Nagler, Arnon .

CLINICAL CANCER RESEARCH, 2008, 14 (10) :3044-3051

[7] Activated T cells armed with bispecific antibodies kill tumor targets [J].

Bhutani, Divaya ;

Lum, Lawrence G. .

CURRENT OPINION IN HEMATOLOGY, 2015, 22 (06) :476-483

[8] B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma [J].

Carpenter, Robert O. ;

Evbuomwan, Moses O. ;

Pittaluga, Stefania ;

Rose, Jeremy J. ;

Raffeld, Mark ;

Yang, Shicheng ;

Gress, Ronald E. ;

Hakim, Frances T. ;

Kochenderfer, James N. .

CLINICAL CANCER RESEARCH, 2013, 19 (08) :2048-2060

[9] Elotuzumab directly enhances NK cell cytotoxicity against myeloma via CS1 ligation: evidence for augmented NK cell function complementing ADCC [J].

Collins, Shauna M. ;

Bakan, Courtney E. ;

Swartzel, Gina D. ;

Hofmeister, Craig C. ;

Efebera, Yvonne A. ;

Kwon, Hakju ;

Starling, Gary C. ;

Ciarlariello, David ;

Bhaskar, Shakthi ;

Briercheck, Edward L. ;

Hughes, Tiffany ;

Yu, Jianhua ;

Rice, Audie ;

Benson, Don M., Jr. .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2013, 62 (12) :1841-1849

[10] Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors [J].

de Weers, Michel ;

Tai, Yu-Tzu ;

van der Veer, Michael S. ;

Bakker, Joost M. ;

Vink, Tom ;

Jacobs, Danielle C. H. ;

Oomen, Lukas A. ;

Peipp, Matthias ;

Valerius, Thomas ;

Slootstra, Jerry W. ;

Mutis, Tuna ;

Bleeker, Wim K. ;

Anderson, Kenneth C. ;

Lokhorst, Henk M. ;

van de Winkel, Jan G. J. ;

Parren, Paul W. H. I. .

JOURNAL OF IMMUNOLOGY, 2011, 186 (03) :1840-1848

← 1 2 3 4 5 6 →